Abstract
Ischemic heart disease is more prevalent in men than in women. The remodeling of extracellular matrix, is a structural correlate of heart failure of ischemic origin and proliferation of cardiac fibroblasts is a key factor in this remodeling. We asked if proliferative response of male and female cardiac fibroblasts is differentially susceptible to hypoxia. DNA synthesis, using 3H-thymidine incorporation was compared under hypoxia (2% O2) in cardiac fibroblasts obtained from adult, age-matched male and female rat heart. In female cells DNA synthesis remained unchanged under hypoxia and this resistance was dependent on tyrosine kinase activation, as it was abolished in the presence of genistein, a tyrosine kinase inhibitor. Male cells, on the other hand, were susceptible to hypoxia and their DNA synthesis was reduced significantly (70%, (p < 0.0001). This effect was partially reversed by inhibition of tyrosine kinase. Western analysis showed a higher abundance of tyrosine phosphorylated proteins in male cells compared to female cells as well as differences in molecular weight of basal and hypoxia-induced tyrosine-phosphorylated proteins between male and female cells. The presence of estrogen (17-β estradiol, 10 nM) altered the response of both cells to hypoxia. In female cells the combined effect of hypoxia and estrogen led to inhibition of DNA synthesis, whereas in male cells estrogen partially reversed the hypoxia-induced inhibition of DNA synthesis (37% (p < 0.01) inhibition in the presence of estrogen vs. 70% (p < 0.0001) inhibition in the absence of estrogen). The effects of estrogen in male and female cells were mediated via estrogen receptors as they were reversed by the pure anti-estrogen, ICI 182,780. Western analysis of cell lysate showed hypoxia-induced increase in the level of estrogen receptor β in both male and female cells. Gel shift analysis showed hypoxia-induced increase in cytoplasmic ERE (estrogen response element)-binding activity and decrease in nuclear ERE-binding in male cells. In female cells cytoplasmic and nuclear ERE-binding activities remained unchanged under hypoxia. Together, these data demonstrate that while female cells are resistant to hypoxia-induced inhibition in DNA synthesis, male cells are susceptible; intracellular pathways involving tyrosine phosphorylation are involved in the response of both cells; and estrogen, via estrogen-receptor-dependent mechanisms, differentially alters the response of male and female cells to hypoxia.
Similar content being viewed by others
References
Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Conner E: Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association. Circulation 96: 2468–2482, 1997
Isles CG, Hole DJ, Hawthorne VM, Lever AF: Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: Comparison with men. Lancet 339: 702–706, 1992
Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E: Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 260: H1406–H1414, 1991
Volders PG, Willems IE, Cleutjens JP: Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 25: 1317–1323, 1993
Whittaker P, Boughner DR, Kloner RA: Role of collagen in acute myocardial infarct expansion. Circulation 84: 2123–2134, 1991
Schaper J: Effect of multiple ischemic events on human myocardium: An ultrastructural study. Eur Heart J 9: 141–149, 1998
Mandes LA, Davidoff R, Cupples LA, Ryan TJ, Jacobs AK: Congestive heart failure in patients with coronary artery disease: The gender paradox. Am Heart J 134: 207–212, 1997
Ho KKL, Anderson KM, Kannel WB, Grossmann W, Levy D: Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation 88: 107–115, 1993
Gardin JM, Wagenknecht LE, Anton-Culver ?, Flack J, Gidding S, Jurosaki T, Wong ND, Manolio TA: Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white men and women. Circulation 92: 380–387, 1995
Kuizinga MC, Smits JFM, Arends JW, Daemen MJAP: AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol 30: 425–434, 1998
Agocha A, Eghbali-Webb M: Hypoxia regulates DNA synthesis and collagen type I production in human cardiac fibroblasts: Effects of transforming growth factor-β1, thyroid hormone, angiotensin II and basic fibroblast growth factor. J Mol Cell Cardiol 29: 2233–2244, 1997
Lee H-W, Eghbali-Webb M: Estrogen enhances proliferation of cardiac fibroblasts via mitogen-activated protein kinase-and estrogen receptor-dependent pathways. J Mol Cell Cardiol 30: 1359–1368, 1998
Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S: Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vivo model of load-induced cardiac hypertrophy. J Biol Chem 267: 10551–10560, 1992
Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM: Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245–1254, 1993
Sigel AV, Centrella M, Eghbali-Webb M: Regulation of proliferative response of cardiac fibroblasts by transforming growth factor-β1. J Mol Cell Cardiol 28: 1921–1929, 1996
Simm A, Nestler M, Hoppe V: PDGF-AA, a potent mitogen for cardiac fibroblasts from adult rats. J Mol Cell Cardiol 29: 357–368, 1997
Kacimi R, Karliner JS, Koudssi F, Long CS: Expression and regulation of adhesion molecules in cardiac cells by cytokines: Response to acute hypoxia. Circ Res 23: 576–586, 1998
Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328: 1069–1075, 1993
Dubey RK, Gillespie DG, Jackson EK, Keller PJ: 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 31: 522–528, 1998
Grohe C, Kahlert S, Lobbert K, Van Eickels M, Stimpel M, Vetter H, Neyses L: Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth. Br J Pharmacol 121: 1350–1354, 1997
Grohe C, Kahlert S, Lobbert K, Vetter H: Expression of estrogen receptor alpha and beta in rat heart: Role of local estrogen synthesis. J Endocrinol 156: R1–R7, 1998
Eghbali M, Tomek R, Sukhatme V, Woods C, Bhambi B: Differential effects of transforming growth factor-β1 and phorbol mirystate acetate on cardiac fibroblasts: Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 69: 483–490, 1991
Eghbali M: Cellular origin and distribution of transforming growth factor-β1 in the normal rat myocardium. Cell Tiss Res 256: 553–558, 1989
Migliaccio A, Di Domenico M, Castoria G, De Falco A, Bontempo P, Nola E, Auricchio F: Tyrosine kinase/p21ras/Map-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292–1300, 1996
Wakeling AE, Bowler J: Novel antiestrogens without partial agonist activity. J Steroid Biochem 31: 645–653, 1988
Akiyama T, Nakagawa S, Ogawara H, Watanabe S, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592–5595, 1987
Shapiro DJ, Sharp PA, Wahli WW, Keller M: A high-efficiency Hela cell nuclear transcription extract. DNA 7: 47–55, 1988
Lee H-W, Klein LE, Raser J, Eghbali-Webb M: An activator protein-1 (AP-1) response element on pro α1(l) collagen gene is necessary for thyroid hormone-induced inhibition of promoter activity in cardiac fibroblasts. J Mol Cell Cardiol 30: 2495–2506, 1998
Klein-Hiptass L, Schorpp M, Wagner U, Ryttel GU: An estrogen-responsive element derived from the 5' flanking region of the xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053–1061, 1986
Arnold SF, Vorojeikina DP, Notides AC: Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem 270: 30205–30212, 1995
Kadonaga JT, Tijian R: Affinity purification of sequence-specific DNA-binding proteins. Proc Natl Acad Sci 83: 5889–5893, 1986
Guerra S, Leri A, Wang X, Finaton N, Loretto C, Beltrami CA, Kajstura J, Anversa P: Myocyte death in the failing human heart is gender dependent. Circ Res 85: 856–866, 1999
Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beakle CM, McNeill JG, Pool-Wilson PA: 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not in men with coronary heart disease. Circulation 92: 24–30, 1995
Huanh A, Sun D, Koller A, Kaley G: Gender differences in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am J Physiol 272: H1804–H1809, 1997
Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci 93: 5925–5930, 1996
Mosselman S, Polman J, Dijkema R: ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49–53, 1996
Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol 11: 353–365, 1997
Kuiper GGJM, Carlson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138: 863–870, 1997
Thenot S, Bonnet S, Boulahtouf A, Margeat E, Royer CA, Borgna JL, Cavailles V: Effect of ligand and DNA-binding on the interaction between human transcription intermediary factor 1 alpha and estrogen receptors. Mol Endocrinol 12: 2137–2150, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Griffin, M., Lee, HW., Zhao, L. et al. Gender-related differences in proliferative response of cardiac fibroblasts to hypoxia. Mol Cell Biochem 215, 21–30 (2000). https://doi.org/10.1023/A:1026585420021
Issue Date:
DOI: https://doi.org/10.1023/A:1026585420021